middl
east
respiratori
syndrom
mer
coronaviru
merscov
first
identifi
continu
threaten
human
health
worldwid
mer
vaccin
licens
human
use
reinforc
urgenc
develop
safe
efficaci
vaccin
prevent
mer
merscov
spike
protein
form
trimer
receptorbind
domain
rbd
serv
vaccin
target
nevertheless
protect
efficaci
rbd
nativ
trimer
form
never
evalu
studi
trimer
protein
rbdfd
gener
fuse
rbd
foldon
trimer
motif
bound
strongli
receptor
merscov
dipeptidyl
peptidas
elicit
robust
rbdspecif
neutral
antibodi
mice
maintain
longterm
neutral
activ
merscov
infect
rbdfd
potent
protect
transgen
mice
lethal
merscov
challeng
result
suggest
merscov
rbd
trimer
form
maintain
nativ
conform
induc
protect
neutral
antibodi
make
candid
therapeut
develop
middl
east
respiratori
syndrom
mer
coronaviru
merscov
first
identifi
saudi
arabia
sinc
result
increas
incid
human
infect
zaki
et
al
chan
et
al
rha
et
al
octob
total
laboratoryconfirm
mer
case
includ
death
mortal
report
worldwid
http
wwwwhoint
emergenciesmerscoven
bat
regard
natur
reservoir
merscov
potenti
mechan
drive
battohuman
transmiss
merscov
investig
compar
merscov
close
relat
bat
coronaviru
memish
et
al
ithet
et
al
cui
et
al
wang
et
al
dromedari
camel
shown
import
intermedi
host
merscov
consid
key
stop
merscov
transmiss
adney
et
al
yusof
et
al
gossner
et
al
sever
outbreak
merscov
south
korea
demonstr
abil
viru
caus
humantohuman
transmiss
khan
et
al
ki
continu
spread
merscov
increas
mer
case
highlight
urgent
need
develop
effect
safe
vaccin
merscov
nativ
spike
merscov
envelop
glycoprotein
present
trimer
viru
surfac
cleav
viru
infect
host
cell
proteas
subunit
respons
merscov
bind
host
cell
express
viral
receptor
dipeptidyl
peptidas
via
receptorbind
domain
rbd
raj
et
al
lu
et
al
wang
et
al
chen
et
al
li
meanwhil
engag
fusion
viru
cell
surfac
membran
thu
mediat
entri
merscov
target
cell
j
lu
et
al
activ
make
merscov
protein
particular
rbd
import
vaccin
target
du
et
al
du
et
al
et
al
et
al
number
fragment
identifi
constitu
merscov
rbd
fragment
contain
residu
viral
protein
critic
neutral
domain
cnd
respons
induct
neutral
antibodi
immun
anim
et
al
et
al
zhang
et
al
nevertheless
rbd
nativ
trimer
form
never
evalu
protect
efficaci
merscov
infect
foldon
fd
acid
phage
fibritin
trimer
motif
construct
fusion
partner
guid
format
ultrast
protein
fiber
promot
trimer
recombin
fusion
protein
bhardwaj
et
al
papanikolopoul
et
al
sissoeff
et
al
exampl
influenza
viru
hemagglutinin
fdform
trimer
domain
increas
bind
affin
neutral
antibodi
target
stalk
region
viral
krammer
et
al
addit
recombin
trimer
envelop
glycoprotein
induc
effici
broadspectrum
neutral
antibodi
increas
potenc
monomer
protein
diverg
strain
grundner
et
al
report
reinforc
import
mimick
nativ
viral
trimer
structur
design
envelop
glycoproteinbas
subunit
vaccin
howev
imit
conform
structur
merscov
protein
never
attempt
mer
vaccin
design
studi
express
recombin
trimer
rbd
protein
fuse
merscov
rbd
sequenc
residu
fd
trimer
motif
rbdfd
investig
antigen
receptor
bind
affin
immunogen
neutral
potenti
protect
efficaci
merscov
challeng
human
mous
model
outcom
studi
indic
potenti
develop
mer
subunit
vaccin
base
trimer
rbd
merscov
protein
fourto
sixweekold
femal
balbc
mice
fourmonthold
male
femal
mice
use
studi
anim
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
anim
protocol
approv
committe
ethic
anim
experi
new
york
blood
center
permit
number
beij
institut
microbiolog
epidemiolog
permit
number
construct
express
purif
recombin
protein
carri
previous
describ
du
et
al
et
al
et
al
du
et
al
briefli
recombin
rbdfd
residu
merscov
rbd
contain
ctermin
fd
tag
construct
use
higgfc
vector
invivogen
express
transfect
cell
cultur
supernat
recombin
merscov
residu
contain
ctermin
construct
use
express
vector
express
describ
recombin
human
ectodomain
residu
contain
ctermin
express
insect
cell
use
bactobac
express
system
invitrogen
secret
cell
cultur
medium
aforement
histag
protein
purifi
use
ninta
superflow
qiagen
rbdfd
analyz
sdspage
western
blot
previous
describ
et
al
du
et
al
briefli
boil
nonboil
protein
separ
trisglycin
sdspage
gel
transfer
nitrocellulos
membran
block
overnight
nonfat
milk
pbst
blot
incub
h
room
temperatur
merscov
antibodi
three
wash
blot
incub
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
ge
healthcar
h
room
temperatur
signal
visual
use
ecl
western
blot
substrat
reagent
amersham
hyperfilm
ge
healthcar
rbdfd
protein
concentr
mgml
buffer
contain
mm
pb
mm
nacl
analyz
inlin
use
tandem
minidawn
treo
mal
optilab
rex
differenti
refract
index
detector
wyatt
technolog
pepcc
facil
case
western
reserv
univers
protein
load
molar
mass
determin
data
analyz
use
astra
softwar
packag
wyatt
technolog
size
distribut
protein
measur
dynapro
nanostar
wyatt
technolog
bind
rbdfd
protein
receptor
carri
coimmunoprecipit
coip
assay
western
blot
previous
describ
du
et
al
briefli
rbdfd
incub
cell
lysat
ml
plu
ninta
superflow
h
follow
wash
wash
buffer
elut
protein
boil
min
subject
sdspage
western
blot
analysi
detect
bind
use
antibodi
r
system
antimerscov
rbd
antibodi
respect
balbc
mice
immun
rbdfd
previous
describ
et
al
et
al
briefli
mice
subcutan
sc
vaccin
rbdfd
presenc
adjuv
schultz
et
al
boost
immunogen
adjuv
week
week
month
postimmun
pb
plu
adjuv
includ
neg
control
sera
collect
monthli
postfirst
dose
month
detect
merscov
antibodi
respons
andor
neutral
antibodi
elisa
carri
detect
bind
rbdfd
protein
previous
describ
du
et
al
briefli
elisa
plate
precoat
rbdfd
overnight
block
nonfat
milk
h
serial
dilut
ad
plate
incub
h
follow
four
wash
bound
antibodi
sequenti
incub
goat
hrpconjug
antigoat
igg
r
system
antibodi
h
follow
addit
substrat
tmb
invitrogen
h
n
sequenti
absorb
nm
measur
elisa
plate
reader
tecan
bind
rbdfd
protein
merscov
rbdspecif
mous
mab
human
mab
ying
et
al
carri
use
protocol
similar
describ
replac
primari
antibodi
serial
dilut
mab
hrpconjug
antimous
ge
healthcar
antihuman
sigma
igg
antibodi
use
secondari
antibodi
detect
merscov
antibodi
mous
sera
plate
coat
merscov
protein
follow
sequenti
addit
serial
dilut
mous
sera
hrpconjug
antimous
igg
antibodi
invitrogen
assay
carri
previous
describ
modif
du
et
al
briefli
cell
cotransfect
plasmid
encod
envdefect
luciferaseexpress
genom
plasmid
encod
protein
merscov
prototyp
strain
repres
strain
isol
outbreak
carri
respect
mutat
rbd
qiu
et
al
use
calcium
phosphat
method
pseudoviruscontain
supernat
harvest
h
posttransfect
singlecycl
infect
cell
inhibit
assay
cell
incub
serial
dilut
rbdfd
protein
h
follow
remov
proteincontain
media
infect
mer
pseudoviru
neutral
assay
mer
pseudoviru
incub
serial
dilut
mous
sera
h
follow
addit
mixtur
cell
cell
refe
fresh
medium
h
later
lyse
h
cell
lysi
buffer
promega
transfer
luminomet
plate
luciferas
substrat
promega
ad
plate
rel
luciferas
activ
determin
infinit
pro
lumin
tecan
mer
pseudoviru
inhibit
neutral
calcul
previous
describ
chou
express
inhibit
dose
id
neutral
antibodi
titer
nt
respect
microneutr
assay
carri
detect
neutral
antibodi
live
merscov
infect
previous
describ
tao
et
al
et
al
briefli
mous
sera
dilut
serial
tissu
cultur
plate
follow
incub
h
room
temperatur
infecti
merscov
transfer
vero
cell
h
cell
observ
presenc
absenc
virusinduc
cytopath
effect
cpe
neutral
antibodi
titer
determin
reciproc
highest
dilut
sera
complet
inhibit
virusinduc
cpe
least
well
nt
challeng
studi
carri
mice
use
previous
optim
protocol
zhao
et
al
briefli
mice
intramuscularli
im
immun
rbdfd
plu
aluminum
adjuv
boost
week
immun
mice
challeng
merscov
strain
week
later
observ
week
postchalleng
detect
surviv
rate
bodi
weight
patholog
chang
determin
whether
merscov
rbd
contain
cnd
residu
would
form
nativ
trimer
structur
fuse
cterminu
fd
trimer
motif
fig
express
rbdfd
protein
cell
cultur
supernat
character
protein
sdspage
western
blot
analysi
high
molecularweight
band
trimer
shown
nondenatur
nonboil
sampl
time
denatur
boil
protein
monom
fig
left
trimer
molecul
rbdfd
protein
confirm
secmal
analysi
indic
molar
mass
da
fig
result
demonstr
recombin
rbd
form
trimer
conform
presenc
fd
trimer
motif
addit
rbdfd
strong
reactiv
antibodi
recombin
protein
merscov
fig
right
suggest
trimer
rbd
deriv
merscov
protein
investig
antigen
rbdfd
protein
test
bind
affin
neutral
mab
specif
conform
epitop
merscov
rbd
ying
et
al
du
et
al
elisa
data
reveal
rbdfd
bound
strongli
antibodi
bind
occur
dosedepend
manner
fig
suggest
trimer
merscov
rbd
maintain
antigen
requir
recogn
rbdspecif
antibodi
target
conform
epitop
coip
assay
elisa
perform
determin
affin
rbdfd
bind
cellassoci
recombin
respect
coip
result
reveal
two
clear
band
pulldown
sampl
contain
cell
lysat
rbdfd
protein
correspond
size
rbdfd
monom
identifi
fig
antimerscovrbd
fig
antibodi
respect
howev
solubl
rbdfd
protein
alon
could
recogn
either
antimerscovrbd
antibodi
fig
b
result
elisa
reveal
strong
bind
rbdfd
protein
dosedepend
manner
fig
data
confirm
bind
affin
trimer
merscov
rbd
protein
cellassoci
recombin
protein
test
abil
trimer
rbdfd
inhibit
merscov
infect
incub
protein
cell
calcul
correspond
inhibit
infect
id
data
demonstr
rbdfd
strongli
block
mer
pseudoviru
entri
target
cell
id
low
wherea
control
protein
inhibitori
activ
even
highest
concentr
fig
data
suggest
potenti
applic
rbdfd
effect
therapeut
agent
merscov
infect
investig
immunogen
trimer
rbdfd
use
protein
sc
immun
balbc
mice
presenc
adjuv
sinc
protocol
previous
optim
rbdbase
vaccin
test
mous
strain
zhang
et
al
measur
gener
merscov
igg
antibodi
well
subtyp
use
elisa
immun
mous
sera
shown
fig
rbdfd
induc
highli
potent
merscov
igg
antibodi
maintain
least
month
detect
period
expect
background
level
igg
antibodi
respons
induc
control
mice
evalu
subtyp
demonstr
antibodi
respons
could
elicit
rbdfd
least
next
six
month
maintain
titer
similar
higher
induc
month
postimmun
fig
contrast
specif
antibodi
induc
control
mice
inject
pb
data
confirm
high
immunogen
trimer
merscov
rbd
induc
longterm
strong
humor
immun
respons
mice
neutral
antibodi
sera
mice
immun
trimer
rbdfd
detect
mer
pseudoviru
live
mer
unrel
sarscov
rbd
protein
includ
control
data
present
inhibit
dose
id
b
merscov
igg
antibodi
titer
mous
sera
differ
month
use
test
merscov
c
antibodi
titer
mous
sera
month
immun
use
test
antibodi
titer
express
endpoint
dilut
remain
posit
detect
present
mean
titer
sd
five
mice
group
rbdfdinduc
neutral
antibodi
infect
pseudotyp
e
live
f
merscov
strain
well
pseudotyp
merscov
repres
strain
isol
outbreak
respect
g
shown
respect
mutat
rbd
protein
compar
strain
qiu
et
al
neutral
antibodi
titer
calcul
reciproc
highest
dilut
sera
result
complet
inhibit
mer
pseudoviru
infect
e
g
merscovinduc
cpe
f
least
well
nt
mous
sera
month
use
test
data
present
mean
titer
sd
five
mice
group
b
g
pb
includ
control
covbas
neutral
assay
inde
rbdfd
elicit
highli
potent
neutral
antibodi
infect
pseudotyp
live
merscov
prototyp
strain
suscept
vero
cell
respect
maintain
similar
level
month
importantli
antibodi
strongli
crossneutr
infect
mer
pseudovirus
express
protein
diverg
strain
isol
outbreak
demonstr
crossneutr
activ
howev
specif
neutral
antibodi
induc
pb
control
mice
fig
result
suggest
trimer
merscov
rbd
abil
elicit
longterm
potent
neutral
antibodi
mice
investig
abil
trimer
rbdfd
induc
protect
immun
merscov
challeng
util
protein
im
immun
mice
small
anim
model
background
suscept
merscov
infect
zhao
et
al
presenc
aluminum
adjuv
immun
protocol
select
optim
mice
unpublish
data
aluminum
approv
adjuv
use
human
vaccin
lee
nguyen
challeng
immun
mice
merscov
lethal
dose
evalu
surviv
weight
patholog
chang
data
demonstr
rbdfdimmun
mice
surviv
lethal
merscov
infect
fig
mice
neutral
antibodi
titer
rang
averag
live
merscov
infect
viru
challeng
fig
although
challeng
mice
slightli
reduc
weight
day
merscov
challeng
rapidli
recov
normal
weight
fig
contrast
control
mice
background
level
neutral
antibodi
sera
kept
continu
reduct
weight
viru
challeng
mice
die
day
fig
observ
patholog
chang
challeng
mous
lung
reveal
almost
normal
lung
tissu
rbdfdimmun
mice
fig
lung
tissu
similar
normal
mice
fig
slightli
thicken
alveolar
wall
fig
comparison
pb
control
mice
challeng
merscov
mark
interstiti
pneumonia
includ
inflammatori
cell
infiltr
alveolar
septal
thicken
focal
exud
hemorrhag
fig
mice
immun
rbdfd
month
old
boost
week
later
challeng
merscov
week
postboost
surviv
week
postchalleng
sacrif
evalu
patholog
chang
thu
result
demonstr
abil
rbdfd
induc
longterm
protect
immun
age
mice
merscov
infect
rapid
develop
safe
efficaci
vaccin
high
potenc
becom
first
prioriti
prevent
continu
infect
merscov
human
previous
demonstr
rbd
fragment
contain
residu
merscov
protein
critic
neutral
domain
cnd
capabl
induc
neutral
antibodi
merscov
infect
et
al
du
et
al
du
et
al
henc
import
target
develop
subunit
vaccin
known
nativ
merscov
protein
form
trimer
cleav
form
function
subunit
lu
et
al
du
et
al
still
unknown
whether
trimer
form
rbd
cnd
merscov
protein
induc
protect
immun
merscov
infect
fd
trimer
motif
previous
fuse
recombin
protein
influenza
viru
ha
glycoprotein
promot
form
trimer
structur
subsequ
stabil
protein
broaden
increas
immunogen
infect
diverg
viru
strain
grundner
et
al
g
gao
et
al
nkolola
et
al
du
et
al
li
et
al
use
merscov
rbd
fuse
fd
rbdfd
model
antigen
studi
attempt
gener
merscov
rbd
trimer
evalu
antigen
receptor
bind
affin
immunogen
neutral
potenti
protect
efficaci
merscov
infect
inde
rbdfd
protein
form
trimer
structur
bound
strongli
merscov
rbdspecif
conform
epitopetarget
mab
well
merscov
receptor
demonstr
capac
elicit
highli
efficaci
igg
antibodi
along
antibodi
respons
result
suggest
trimer
merscov
rbd
maintain
potent
antigen
strong
receptorbind
affin
high
immunogen
induc
robust
antibodi
respons
immun
anim
particularli
rbdfd
protein
abl
induc
longterm
highli
potent
neutral
antibodi
infect
live
pseudotyp
merscov
diverg
strain
isol
outbreak
possibl
rbdfd
form
trimer
structur
mimic
nativ
conform
cnd
merscov
protein
thu
elicit
vigor
crossneutr
antibodi
due
low
express
rbd
protein
monom
mammalian
cell
express
system
unabl
obtain
suffici
monomer
rbd
protein
includ
control
studi
nevertheless
surviv
rate
minim
patholog
chang
rbdfdimmun
mice
demonstr
high
protect
efficaci
lethal
merscov
challeng
improv
protect
immun
rbdtrimer
could
optim
stabil
trimer
structur
disulfid
bond
ad
trimer
motif
adjust
linker
sequenc
rbd
fd
combin
approach
report
viral
protein
yang
et
al
yang
et
al
ring
et
al
sinc
rbdfd
induc
background
level
cell
respons
data
shown
protect
efficaci
larg
associ
neutral
antibodi
evidenc
mice
surviv
merscov
infect
rel
high
serum
neutral
antibodi
titer
suggest
neutral
antibodi
rather
cellular
immun
respons
may
play
key
role
prevent
merscov
infect
trimer
rbdbase
subunit
vaccin
overal
report
confirm
capabl
merscov
rbd
critic
neutral
epitop
form
trimer
structur
result
induct
strong
humor
immun
respons
potent
neutral
antibodi
signific
protect
efficaci
emphas
import
maintain
nativ
conform
structur
protein
develop
mer
subunit
vaccin
context
studi
provid
valuabl
guidanc
ration
design
efficaci
subunit
vaccin
merscov
virus
class
membran
fusion
protein
